Citius Pharmaceuticals Ownership | Who Owns Citius Pharmaceuticals?

Overview Forecast RevenueFinancials Chart

Citius Pharmaceuticals Ownership Summary

Citius Pharmaceuticals is owned by 0.04% institutional investors, 5.74% insiders, and 94.22% retail investors. Blackrock is the largest institutional shareholder, holding 1.14% of CTXR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.60% of its assets in Citius Pharmaceuticals shares.

CTXR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Citius Pharmaceuticals	0.04%	5.74%	94.22%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	1.81M	1.14%	$1.05M
Northern trust	1.06M	0.66%	$615.83K
Bank of america corp /de/	159.42K	0.10%	$92.94K
Barclays	37.82K	0.02%	$22.00K
Advisor group	40.28K	0.02%	$20.14K
Ifp advisors	33.33K	0.02%	$4.45K
Rhumbline advisers	30.04K	0.02%	$17.54K
Citadel advisors	24.70K	0.02%	$14.42K
Morgan stanley	9.74K	0.01%	$5.69K
Macquarie group	6.89K	0.00%	$4.02K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ifp advisors	33.33K	0.00%	$4.45K
Advisor group	40.28K	0.00%	$20.14K
Northern trust	1.06M	0.00%	$615.83K
Geode capital management	-	-	-
Wr wealth planners	-	-	-
Legal & general group	-	-	-
Proshare advisors	-	-	-
New york state common retirement fund	-	-	-
Nelson, van denburg & campbell wealth management group	-	-	-
Blackrock	1.81M	-	$1.05M

Top Buyers

Holder	Shares	% Assets	Change
Bank of america corp /de/	159.42K	-	107.23K
Citadel advisors	24.70K	-	24.70K
Macquarie group	6.89K	-	6.89K
Russell investments group	5.46K	-	5.46K
Ifp advisors	33.33K	0.00%	-

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-7.28M
Blackrock	1.81M	-	-6.92M
Vanguard group	-	-	-6.44M
Geode capital management	-	-	-1.88M
Blackrock funding, inc. /de	-	-	-1.81M

New Positions

Holder	Shares	% Assets	Change	Value
Macquarie group	6.89K	-	6.89K	$4.02K
Russell investments group	5.46K	-	5.46K	$3.19K

Sold Out

Holder	Change
Eversource wealth advisors	-16.00
Nelson, van denburg & campbell wealth management group	-18.00
Farther finance advisors	-80.00
Wr wealth planners	-100.00
Pnc financial services group	-177.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	3	-94.92%	76,616	-99.68%	-	0.02%	-	-100.00%	1	-96.00%
Sep 30, 2024	55	-21.43%	23,175,356	-23.61%	13	3.66%	12	-62.50%	25	38.89%
Jun 30, 2024	70	-2.78%	30,339,564	12.37%	19	6.61%	32	14.29%	18	-21.74%
Mar 31, 2024	72	-4.00%	26,999,770	0.67%	16	5.97%	28	-24.32%	23	91.67%
Dec 31, 2023	75	-1.32%	26,820,000	7.67%	16	6.43%	37	32.14%	12	-36.84%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	4.14M	2.60%	-1.00
Vanguard Total Stock Mkt Idx Inv	165.58K	1.93%	-
Vanguard Institutional Extnd Mkt Idx Tr	78.31K	0.91%	-
Fidelity Extended Market Index	36.65K	0.43%	-233.00
NT R2000 Index Fund - NL	316.31K	0.17%	-58.09K
NT R2000 Value Index Fund - NL	279.80K	0.15%	-55.32K
NT R2000 Index Fund - DC - NL - 2	250.30K	0.14%	-47.02K
Northern Trust Russell 2000 Value Index	249.69K	0.14%	6.16K
NT R2000 Value Index Fund - L	249.69K	0.14%	6.16K
Fidelity Total Market Index	11.65K	0.14%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 27, 2019	Mazur Leonard L	Executive Chairman	Buy	$1.72M
Sep 27, 2019	Mazur Leonard L	Executive Chairman	Buy	$2.00M
Sep 27, 2019	HOLUBIAK MYRON Z	President and CEO	Buy	$500.00K
Sep 27, 2019	HOLUBIAK MYRON Z	President and CEO	Buy	$430.12K
Apr 03, 2019	Mazur Leonard L	Executive Chairman	Buy	$1.80M

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q1	-	-

CTXR Ownership FAQ

Who Owns Citius Pharmaceuticals?

Citius Pharmaceuticals shareholders are primarily institutional investors at 0.04%, followed by 5.74% insiders and 94.22% retail investors. The average institutional ownership in Citius Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Citius Pharmaceuticals falls below.

Who owns the most shares of Citius Pharmaceuticals?

Citius Pharmaceuticals’s largest shareholders are Blackrock (1.81M shares, 1.14%), Northern trust (1.06M shares, 0.66%), and Bank of america corp /de/ (159.42K shares, 0.10%). Together, they hold 1.90% of Citius Pharmaceuticals’s total shares outstanding.

Does Blackrock own Citius Pharmaceuticals?

Yes, BlackRock owns 1.14% of Citius Pharmaceuticals, totaling 1.81M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.05M$. In the last quarter, BlackRock decreased its holdings by -6.921M shares, a -79.31% change.

Who is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ifp advisors is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 33.33K Citius Pharmaceuticals shares, valued at 4.45K$.

Who is the top mutual fund holder of Citius Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Citius Pharmaceuticals shares, with 2.60% of its total shares outstanding invested in 4.14M Citius Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools